Top Markets
Coin of the day
Immunotech Laboratories, Inc. Immunotech Laboratories, Inc.

Immunotech Laboratories, Inc.

IMMB
Rankning i aktier #40594
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Aktiekurs
$0.0002
Senast synkroniserad: 2026-08-12
Marknadsvärde
$114.99K
Förändring (1 dag)
0.00%
Förändring (1 år)
100.00%
Land
US
Handel Immunotech Laboratories, Inc. (IMMB)

Kategori

Aktiekurshistorik för Immunotech Laboratories, Inc. (IMMB)
Högsta slutkurs: $0.00 den 2026-08-01

Lägsta slutkurs: $0.00 den 2022-03-01
Aktiekurshistorik för Immunotech Laboratories, Inc. från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -40.00%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE